Is RXRX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Recursion Pharmaceuticals 10 years ago, but if you had invested on Thursday 15th of April 2021 when the price was $18.00, you would have made a loss of $-11.96 per share or -66.44%
Yes, the average daily trading liquidity for Recursion Pharmaceuticals is $36.58 million. You should therefore be able to get in and out of your positions relatively fast.
Recursion Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Recursion Pharmaceuticals to be medium [0.7 out of 1]